Cutler Group LP Enanta Pharmaceuticals Inc Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$41.16 - $47.47 $74,911 - $86,395	-1,820 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$43.36 - $53.53 $22,547 - $27,835	520 Added 40.0%	1,820 $83,000
Q2 2020 Jul 22, 2020	BUY	$46.37 - $57.58 $60,281 - $74,854	1,300 New	1,300 $65,000
Q2 2019 Aug 09, 2019	SELL	$81.3 - $97.35 $113,820 - $136,290	-1,400 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$69.08 - $105.66 $89,804 - $137,358	1,300 Added 1300.0%	1,400 $133,000
Q3 2018 Nov 07, 2018	SELL	$85.46 - $126.37 $42,730 - $63,185	-500 Reduced 83.33%	100 $8,000
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $4,092 - $6,025	50 Added 9.09%	600 $69,000
Q1 2018 May 11, 2018	BUY	$57.91 - $92.15 $31,850 - $50,682	550 New	550 $44,000
Q4 2017 Jan 17, 2018	SELL	$45.65 - $59.37 $639 - $831	-14 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$37.91 - $46.8 $530 - $655	14	14 $0

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $131M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.